Turn any article into a podcast. Upgrade now to start listening.
Members can share articles with friends & family to bypass the paywall.
The U.S. Food and Drug Administration shocked the vaccine industry earlier this month by refusing to evaluate Moderna’s new mRNA flu vaccine for approval. The biotech giant had spent more than a billion dollars testing the new shot, which had shown promising results compared to a standard flu shot in a 40,000-person clinical trial.
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source



